Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
LIMPII/SR-B2 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP18458325UL
Description
LIMPII/SR-B2 Polyclonal specifically detects LIMPII/SR-B2 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
LIMPII/SR-B2 | |
Polyclonal | |
Western Blot 0.4 ug/ml, Immunohistochemistry, Immunohistochemistry-Paraffin 1:200-1:500 | |
AMRF, CD36 antigen, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2(lysosomal integral membrane protein II), CD36L2LIMP II, HLGP85, LGP85, LIMP-2,85 kDa lysosomal sialoglycoprotein scavenger receptor class B, member 2, LIMPIICD36 antigen-like 2, lysosome membrane protein 2, Lysosome membrane protein II, Scavenger receptor class B member 2,85 kDa lysosomal membrane sialoglycoprotein, scavenger receptor class B, member 2, SR-BII | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
SCARB2 | |
This antibody was developed against Recombinant Protein corresponding to amino acids:SFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGD | |
25 μL | |
Cellular Markers, Cholesterol Metabolism, Lipid and Metabolism, Lysosome Markers, Signal Transduction | |
950 | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction